LinkedIn Profile

Access Vysera Biomedical historical Linkedin company profile data on number of followers, employee headcount and more
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Headcount change in past 24 months Company Name Sector Industry
private:vyserabiomedical-2 792316 Dec 3rd, 2020 12:00AM Vysera Biomedical Ltd 319 3.00 Open Medical Device Dec 3rd, 2020 03:22PM Dec 3rd, 2020 03:22PM Vysera, which commenced operations in 2005, is a medical devices company located in Galway, Ireland whose principal activity is the development of products and therapies that can be delivered directly to target sites on the inner surface of the gastrointestinal tract ("GI") via conventional, minimally invasive techniques. The company has a developed unique proprietary biomimetic material technology and is applying this technology to address the significant unmet need for gastrointestinal reflux control (GERD). GERD is a condition in which the contents of the stomach regurgitates (refluxes) into the esophagus. This reflux inflames and damages the lining of the esophagus, leading to complications including asthma, bronchitis and Barretts Esophagus (a pre-cancerous condition). The technology has additional applications in urology, obesity and drug delivery which are in the early stages of development. Vysera's Medical Scientific Advisory Board includes world leading clinicians, located at the Mayo Clinic, Beth Israel Hospital (Harvard Medical School) and Sahlgrenska Hospital in Gothenburg, Sweden. The Medical Scientific Advisory Board provides input and direction to product design, application and associated clinical procedures; with the clinicians providing facilities for extensive testing and product evaluation in a pre-clinical and clinical environment. Open BMR House, Parkmore Business Park West Galway IE Ireland Vysera Biomedical Pharmaceuticals & Biotechnology
private:vyserabiomedical-2 792316 Dec 2nd, 2020 12:00AM Vysera Biomedical Ltd 319 3.00 Open Medical Device Dec 2nd, 2020 05:09PM Dec 2nd, 2020 05:09PM Vysera, which commenced operations in 2005, is a medical devices company located in Galway, Ireland whose principal activity is the development of products and therapies that can be delivered directly to target sites on the inner surface of the gastrointestinal tract ("GI") via conventional, minimally invasive techniques. The company has a developed unique proprietary biomimetic material technology and is applying this technology to address the significant unmet need for gastrointestinal reflux control (GERD). GERD is a condition in which the contents of the stomach regurgitates (refluxes) into the esophagus. This reflux inflames and damages the lining of the esophagus, leading to complications including asthma, bronchitis and Barretts Esophagus (a pre-cancerous condition). The technology has additional applications in urology, obesity and drug delivery which are in the early stages of development. Vysera's Medical Scientific Advisory Board includes world leading clinicians, located at the Mayo Clinic, Beth Israel Hospital (Harvard Medical School) and Sahlgrenska Hospital in Gothenburg, Sweden. The Medical Scientific Advisory Board provides input and direction to product design, application and associated clinical procedures; with the clinicians providing facilities for extensive testing and product evaluation in a pre-clinical and clinical environment. Open BMR House, Parkmore Business Park West Galway IE Ireland Vysera Biomedical Pharmaceuticals & Biotechnology
private:vyserabiomedical-2 792316 Dec 1st, 2020 12:00AM Vysera Biomedical Ltd 319 3.00 Open Medical Device Dec 1st, 2020 03:44PM Dec 1st, 2020 03:44PM Vysera, which commenced operations in 2005, is a medical devices company located in Galway, Ireland whose principal activity is the development of products and therapies that can be delivered directly to target sites on the inner surface of the gastrointestinal tract ("GI") via conventional, minimally invasive techniques. The company has a developed unique proprietary biomimetic material technology and is applying this technology to address the significant unmet need for gastrointestinal reflux control (GERD). GERD is a condition in which the contents of the stomach regurgitates (refluxes) into the esophagus. This reflux inflames and damages the lining of the esophagus, leading to complications including asthma, bronchitis and Barretts Esophagus (a pre-cancerous condition). The technology has additional applications in urology, obesity and drug delivery which are in the early stages of development. Vysera's Medical Scientific Advisory Board includes world leading clinicians, located at the Mayo Clinic, Beth Israel Hospital (Harvard Medical School) and Sahlgrenska Hospital in Gothenburg, Sweden. The Medical Scientific Advisory Board provides input and direction to product design, application and associated clinical procedures; with the clinicians providing facilities for extensive testing and product evaluation in a pre-clinical and clinical environment. Open BMR House, Parkmore Business Park West Galway IE Ireland Vysera Biomedical Pharmaceuticals & Biotechnology
private:vyserabiomedical-2 792316 Nov 30th, 2020 12:00AM Vysera Biomedical Ltd 319 3.00 Open Medical Device Nov 29th, 2020 09:41PM Nov 30th, 2020 06:39PM Vysera, which commenced operations in 2005, is a medical devices company located in Galway, Ireland whose principal activity is the development of products and therapies that can be delivered directly to target sites on the inner surface of the gastrointestinal tract ("GI") via conventional, minimally invasive techniques. The company has a developed unique proprietary biomimetic material technology and is applying this technology to address the significant unmet need for gastrointestinal reflux control (GERD). GERD is a condition in which the contents of the stomach regurgitates (refluxes) into the esophagus. This reflux inflames and damages the lining of the esophagus, leading to complications including asthma, bronchitis and Barretts Esophagus (a pre-cancerous condition). The technology has additional applications in urology, obesity and drug delivery which are in the early stages of development. Vysera's Medical Scientific Advisory Board includes world leading clinicians, located at the Mayo Clinic, Beth Israel Hospital (Harvard Medical School) and Sahlgrenska Hospital in Gothenburg, Sweden. The Medical Scientific Advisory Board provides input and direction to product design, application and associated clinical procedures; with the clinicians providing facilities for extensive testing and product evaluation in a pre-clinical and clinical environment. Open BMR House, Parkmore Business Park West Galway IE Ireland Vysera Biomedical Pharmaceuticals & Biotechnology
private:vyserabiomedical-2 792316 Nov 28th, 2020 12:00AM Vysera Biomedical Ltd 319 3.00 Open Medical Device Nov 28th, 2020 05:14PM Nov 28th, 2020 05:14PM Vysera, which commenced operations in 2005, is a medical devices company located in Galway, Ireland whose principal activity is the development of products and therapies that can be delivered directly to target sites on the inner surface of the gastrointestinal tract ("GI") via conventional, minimally invasive techniques. The company has a developed unique proprietary biomimetic material technology and is applying this technology to address the significant unmet need for gastrointestinal reflux control (GERD). GERD is a condition in which the contents of the stomach regurgitates (refluxes) into the esophagus. This reflux inflames and damages the lining of the esophagus, leading to complications including asthma, bronchitis and Barretts Esophagus (a pre-cancerous condition). The technology has additional applications in urology, obesity and drug delivery which are in the early stages of development. Vysera's Medical Scientific Advisory Board includes world leading clinicians, located at the Mayo Clinic, Beth Israel Hospital (Harvard Medical School) and Sahlgrenska Hospital in Gothenburg, Sweden. The Medical Scientific Advisory Board provides input and direction to product design, application and associated clinical procedures; with the clinicians providing facilities for extensive testing and product evaluation in a pre-clinical and clinical environment. Open BMR House, Parkmore Business Park West Galway IE Ireland Vysera Biomedical Pharmaceuticals & Biotechnology
private:vyserabiomedical-2 792316 Nov 27th, 2020 12:00AM Vysera Biomedical Ltd 319 3.00 Open Medical Device Nov 27th, 2020 01:40PM Nov 27th, 2020 01:40PM Vysera, which commenced operations in 2005, is a medical devices company located in Galway, Ireland whose principal activity is the development of products and therapies that can be delivered directly to target sites on the inner surface of the gastrointestinal tract ("GI") via conventional, minimally invasive techniques. The company has a developed unique proprietary biomimetic material technology and is applying this technology to address the significant unmet need for gastrointestinal reflux control (GERD). GERD is a condition in which the contents of the stomach regurgitates (refluxes) into the esophagus. This reflux inflames and damages the lining of the esophagus, leading to complications including asthma, bronchitis and Barretts Esophagus (a pre-cancerous condition). The technology has additional applications in urology, obesity and drug delivery which are in the early stages of development. Vysera's Medical Scientific Advisory Board includes world leading clinicians, located at the Mayo Clinic, Beth Israel Hospital (Harvard Medical School) and Sahlgrenska Hospital in Gothenburg, Sweden. The Medical Scientific Advisory Board provides input and direction to product design, application and associated clinical procedures; with the clinicians providing facilities for extensive testing and product evaluation in a pre-clinical and clinical environment. Open BMR House, Parkmore Business Park West Galway IE Ireland Vysera Biomedical Pharmaceuticals & Biotechnology
private:vyserabiomedical-2 792316 Nov 26th, 2020 12:00AM Vysera Biomedical Ltd 319 3.00 Open Medical Device Nov 25th, 2020 08:47PM Nov 25th, 2020 08:47PM Vysera, which commenced operations in 2005, is a medical devices company located in Galway, Ireland whose principal activity is the development of products and therapies that can be delivered directly to target sites on the inner surface of the gastrointestinal tract ("GI") via conventional, minimally invasive techniques. The company has a developed unique proprietary biomimetic material technology and is applying this technology to address the significant unmet need for gastrointestinal reflux control (GERD). GERD is a condition in which the contents of the stomach regurgitates (refluxes) into the esophagus. This reflux inflames and damages the lining of the esophagus, leading to complications including asthma, bronchitis and Barretts Esophagus (a pre-cancerous condition). The technology has additional applications in urology, obesity and drug delivery which are in the early stages of development. Vysera's Medical Scientific Advisory Board includes world leading clinicians, located at the Mayo Clinic, Beth Israel Hospital (Harvard Medical School) and Sahlgrenska Hospital in Gothenburg, Sweden. The Medical Scientific Advisory Board provides input and direction to product design, application and associated clinical procedures; with the clinicians providing facilities for extensive testing and product evaluation in a pre-clinical and clinical environment. Open BMR House, Parkmore Business Park West Galway IE Ireland Vysera Biomedical Pharmaceuticals & Biotechnology
private:vyserabiomedical-2 792316 Nov 24th, 2020 12:00AM Vysera Biomedical Ltd 319 3.00 Open Medical Device Nov 24th, 2020 04:20PM Nov 24th, 2020 04:20PM Vysera, which commenced operations in 2005, is a medical devices company located in Galway, Ireland whose principal activity is the development of products and therapies that can be delivered directly to target sites on the inner surface of the gastrointestinal tract ("GI") via conventional, minimally invasive techniques. The company has a developed unique proprietary biomimetic material technology and is applying this technology to address the significant unmet need for gastrointestinal reflux control (GERD). GERD is a condition in which the contents of the stomach regurgitates (refluxes) into the esophagus. This reflux inflames and damages the lining of the esophagus, leading to complications including asthma, bronchitis and Barretts Esophagus (a pre-cancerous condition). The technology has additional applications in urology, obesity and drug delivery which are in the early stages of development. Vysera's Medical Scientific Advisory Board includes world leading clinicians, located at the Mayo Clinic, Beth Israel Hospital (Harvard Medical School) and Sahlgrenska Hospital in Gothenburg, Sweden. The Medical Scientific Advisory Board provides input and direction to product design, application and associated clinical procedures; with the clinicians providing facilities for extensive testing and product evaluation in a pre-clinical and clinical environment. Open BMR House, Parkmore Business Park West Galway IE Ireland Vysera Biomedical Pharmaceuticals & Biotechnology
private:vyserabiomedical-2 792316 Nov 23rd, 2020 12:00AM Vysera Biomedical Ltd 319 3.00 Open Medical Device Nov 23rd, 2020 06:09PM Nov 23rd, 2020 06:09PM Vysera, which commenced operations in 2005, is a medical devices company located in Galway, Ireland whose principal activity is the development of products and therapies that can be delivered directly to target sites on the inner surface of the gastrointestinal tract ("GI") via conventional, minimally invasive techniques. The company has a developed unique proprietary biomimetic material technology and is applying this technology to address the significant unmet need for gastrointestinal reflux control (GERD). GERD is a condition in which the contents of the stomach regurgitates (refluxes) into the esophagus. This reflux inflames and damages the lining of the esophagus, leading to complications including asthma, bronchitis and Barretts Esophagus (a pre-cancerous condition). The technology has additional applications in urology, obesity and drug delivery which are in the early stages of development. Vysera's Medical Scientific Advisory Board includes world leading clinicians, located at the Mayo Clinic, Beth Israel Hospital (Harvard Medical School) and Sahlgrenska Hospital in Gothenburg, Sweden. The Medical Scientific Advisory Board provides input and direction to product design, application and associated clinical procedures; with the clinicians providing facilities for extensive testing and product evaluation in a pre-clinical and clinical environment. Open BMR House, Parkmore Business Park West Galway IE Ireland Vysera Biomedical Pharmaceuticals & Biotechnology
private:vyserabiomedical-2 792316 Nov 22nd, 2020 12:00AM Vysera Biomedical Ltd 319 3.00 Open Medical Device Nov 22nd, 2020 05:05PM Nov 22nd, 2020 05:05PM Vysera, which commenced operations in 2005, is a medical devices company located in Galway, Ireland whose principal activity is the development of products and therapies that can be delivered directly to target sites on the inner surface of the gastrointestinal tract ("GI") via conventional, minimally invasive techniques. The company has a developed unique proprietary biomimetic material technology and is applying this technology to address the significant unmet need for gastrointestinal reflux control (GERD). GERD is a condition in which the contents of the stomach regurgitates (refluxes) into the esophagus. This reflux inflames and damages the lining of the esophagus, leading to complications including asthma, bronchitis and Barretts Esophagus (a pre-cancerous condition). The technology has additional applications in urology, obesity and drug delivery which are in the early stages of development. Vysera's Medical Scientific Advisory Board includes world leading clinicians, located at the Mayo Clinic, Beth Israel Hospital (Harvard Medical School) and Sahlgrenska Hospital in Gothenburg, Sweden. The Medical Scientific Advisory Board provides input and direction to product design, application and associated clinical procedures; with the clinicians providing facilities for extensive testing and product evaluation in a pre-clinical and clinical environment. Open BMR House, Parkmore Business Park West Galway IE Ireland Vysera Biomedical Pharmaceuticals & Biotechnology

Request a demo to view additional historical data, and much more.

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.